Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of vortioxetine 20 mg tablets vs Brintellix 20 mg tablets in healthy Thai volunteers under fasting
TCTR20221004002Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vortioxetine (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
vortioxetine
Beyond the preview
Go deeper on TCTR20221004002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221004002.